Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Donate
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Donate

PHASE ONE Foundation

Phase One Foundation logo

Summer 2024
By Colleen Sullivan

PHASE ONE Foundation awarded $370,000 to support a Dana-Farber clinical trial led by Alison O’Neill, MD. The clinical trial aims to test a new intratumoral delivery method for a novel immunotherapy in pediatric patients with relapsed or refractory solid tumors.

, ,

More stories:

Copy link
CopyCopied
Powered by Social Snap